(Circulation. 2001;104:963.)
© 2001 American Heart Association, Inc.
Current Perspective |
From the Dept of Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Tex.
Correspondence to Connie C.W. Hsia, MD, Dept of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9034. E-mail Connie.Hsia{at}utsouthwestern.edu
Key Words: heart failure oxygen cardiovascular diseases lung hypoxia exercise remodeling
| Introduction |
|---|
|
|
|---|
| Regulation of Physiological Reserves |
|---|
|
|
|---|
50 mL/min) is still adequate for handling the usual filtration load; no compensation is needed to sustain a normal lifestyle. However, in reality, the glomerular filtration rate of the remaining kidney gradually increases by some 80%; this is accompanied by an increase in renal mass.1
|
Normally, lung diffusing capacity (DL) increases with pulmonary blood flow up to peak exercise without reaching an upper limit,2 indicating continued recruitment of capillary reserves, which protect arterial O2 saturation (SaO2) in lung disease until DL drops below 50% of normal. After pneumonectomy, blood flow per lung unit doubles and the remaining capillary reserves are recruited.3 Because the peak O2 flux after pneumonectomy remains below that supported by the maximal DL of one lung, no structural adaptation is needed; however, a pneumonectomy elicits compensatory growth of gas exchange tissue, which tends to normalize DL.4 Conversely, a sustained submaximal increase in load elicits adaptation that raises the capacity and restores reserves (Figure 1C). During submaximal exercise training, the average O2 uptake (load) remains far below maximal O2 uptake (
O2max, capacity), but this regular intermittent submaximal loading can increase
O2max by up to 30% over
8 weeks.5
These examples illustrate the regulation of physiological reserves in anticipation of potential internal or external perturbation. Although metabolic systems generally operate far below capacity, reserves protect against the infrequent scenarios when exploiting full capacity may be life-saving. However, maintaining reserves costs metabolic energy and physical space; excessive reserves divert resources and reduce the efficiency of the whole organism. Atrophy of disused capacity is a universal phenomenon in natural selection. In lower eukaryocytes, elimination of excess metabolic capacity confers a distinct competitive survival advantage within a short time span.
| Regulation of Multistep Pathways |
|---|
|
|
|---|
|
| Adaptation in Oxygen Transport |
|---|
|
|
|---|
O2max, but enhancing maximal ventilation or DL has a negligible effect. Up to peak exercise, SaO2 remains normal, indicating that pulmonary gas exchange is not limiting. Breathing 100% O2 improves
O2max without changing ventilation or cardiac output, indicating that mitochondrial O2 use is not limiting. After bed rest, maximal cardiac output and peripheral extraction decline further but can be partially restored by physical training. Physical training increases ventilatory capacity modestly by improving respiratory muscle strength and endurance, but it has little effect on DL at a given cardiac output. Therefore, in untrained individuals, cardiac and skeletal muscles capacities are rate-limiting but DL seems excessive.
|
In well-trained athletes, the transport capacities of cardiac and skeletal muscles are well matched to ventilatory capacity and DL. A further increase in maximal cardiac output raises
O2max only slightly but causes a precipitous fall in SaO2. Increasing minute ventilation at peak exercise may increases
O2max further,9 but peak ventilation becomes constrained by the maximum expiratory flow rate.10 Therefore,
O2max in the athlete is equally sensitive to independent changes of maximal cardiac output, ventilation, and diffusion, ie, coordinated regulation (Figure 4). Changing any one step produces a small change in overall O2 flux. Only by increasing all capacities simultaneously can a correspondingly large gain in maximal O2 transport be produced. Hence, it becomes progressively more difficult to attain further performance improvement in the well-trained athlete.
|
With physical inactivity, cardiac and skeletal muscles rapidly lose their capacities but lung capacity does not diminish significantly, creating an apparent "mismatch." The disparity stems largely from differences in the structural plasticity of muscle and lung. Skeletal muscle is metabolically active and bulky, constituting >40% of body mass and incurring a high energy cost of maintenance; large reserves are not affordable, and unused muscle structure is eliminated through remodeling. In contrast, septal lung tissue constitutes only 1% of body mass and requires comparatively little energy for maintenance; therefore, downsizing septal structure in response to changing O2 flux is less imperative.
Charles Darwin observed that biological structures continually remodel according to changing evolutionary pressures. The hypothesis that no more structure is formed or maintained than is required to satisfy functional demands was termed "symmorphosis" by Weibel.11 Our prehistoric ancestors were presumably athletic, with well-matched O2 transport capacities. With emerging sedentary civilization, energy conservation favors the shedding of unused muscular capacity, while the pressure to downsize lung capacity is less; the rate of remodeling may also be influenced by the differential complexity of these organs. If average physical activity continues to decline, lung structure may also eventually become downsized. Alternatively, maintaining large DL reserves may be advantageous.11 The lung is the only O2 transport organ that interfaces with the environment and is exposed to airborne pathogens, irritants, varying temperature, humidity, and gas tension. Available data suggest that spirometry, elastic recoil, and gas exchange1214 decline with age more rapidly than stroke volume or arteriovenous O2 extraction in the fit subject.15,16 Large DL reserves may protect against aging and facilitate migration to a high altitude, where pulmonary diffusion is the primary factor limiting O2 transport.
Disparate plasticity between muscle and lung allows selective manipulation to increase muscle transport capacity above that of the lung, as exemplified by the thoroughbred racehorse, a species selectively bred over centuries for superior muscle and cardiovascular capacity until these traits exceed what lung structure will support; consequently, pulmonary O2 uptake becomes the bottleneck in O2 transport. At peak exercise, mean pulmonary capillary transit time falls below that required for adequate O2 loading onto hemoglobin; severe hypoxemia and pulmonary arterial hypertension develop and frank pulmonary hemorrhage is common.17 Capacity of the mechanical ventilatory pump is also exceeded, leading to CO2 retention secondary to either a prohibitively elevated respiratory muscle energy requirement or a limit of chemoreceptor drive. Breathing supplemental O2 significantly improves
O2max, evidence that mitochondrial capacity does not limit O2 transport.
| Adaptation in Disturbed Oxygen Transport |
|---|
|
|
|---|
High Altitude Acclimatization
At high altitude, diminished pulmonary O2 uptake is the primary bottleneck in O2 transport. Normal reserves of ventilatory capacity and DL are critical in allowing individuals to maintain adequate SaO2. Patients with restricted lung volume or a pulmonary vascular bed who are unable to increase ventilation or recruit DL have a high morbidity and mortality at altitude. With acclimatization, other organs adjust their capacities to compensate for the reduced O2 supply. The decline in appetite and body weight minimizes energy expenditure. Polycythemia maximizes convective O2 delivery. Initially, maximal cardiac output and heart rate are unchanged and submaximal cardiac output at a given O2 uptake is elevated.18 With acclimatization, maximal cardiac output, stroke volume, and heart rate decline, and submaximal cardiac output at a given O2 uptake returns to sea level baseline19 (Figure 5). The reduction of maximal cardiac output is counterintuitive and has been termed "maladaptive." It is associated with parasympathetic activation, diminished responsiveness to sympathetic stimulation, and intact cardiac contractility, but it is not reversed by vagal blockade and only partially reversed by supplemental O2.1921
|
Figure 6 shows the expected relationships of SaO2 to
O2max as a result of interactions among DL, maximal cardiac output, and altitude in young athletes. At a high altitude, SaO2 declines at a lower
O2max than at sea level. At a given
O2max, SaO2 declines as maximal cardiac output increases due to a lower pulmonary capillary transit time. At sea level, as maximal cardiac output increases from 23 to 32 L/min, there is a large gain in
O2max, with minimal change in SaO2. At a high altitude, the same increase in maximal cardiac output leads to only a small gain in
O2max but a precipitous drop in SaO2. Acute altitude exposure causes large decreases in SaO2 and
O2max with no change in maximal cardiac output. After acclimatization, maximal cardiac output declines, resulting in a large gain in SaO2 with only a small loss in
O2max; the latter loss is readily compensated for by hyperventilation. Thus, maximal cardiac output does not limit
O2max at altitude; increasing maximal cardiac output exacerbates the diffusion limitation, but reducing maximal cardiac output optimizes SaO2 and lowers the myocardial O2 requirement within the constraint imposed by the lower O2 uptake across the lung.
|
With acclimatization, muscle fiber diameter, mitochondrial volume, and oxidative enzymatic capacity decrease.22 Exercise at a high altitude induces enzymes of glycolysis but not the citric acid cycle, respiratory chain, fatty acid oxidation, or ketone body use.23 Muscle morphology superficially resembles disuse atrophy, but capillary density is increased and mitochondria are closer to capillaries, which minimize diffusive resistance to O2 uptake. Downregulation of muscle mass results in just enough aerobic capacity to match pulmonary O2 uptake, so overall metabolic energy wastage is minimized.
Chronic Lung Disease
In moderate-to-severe chronic obstructive pulmonary disease (COPD), maximal cardiac output is reduced; skeletal and respiratory muscle dysfunction develops even in the absence of overt hypoxemia, resting pulmonary hypertension, or exogenous steroid administration.24,25 Some consider COPD a multisystem disease.26 The reduction in maximal cardiac output, attributed to deconditioning, impaired venous return due to elevated intrathoracic pressure, and pulmonary arterial hypertension, resembles the response to altitude exposure. In addition, diaphragm weight and thickness correlate inversely with the histological severity of emphysema,27 a seemingly "paradoxical" response. Because the work of breathing is grossly elevated in COPD and respiratory muscles must work harder, one expects the diaphragm to hypertrophy rather than atrophy. The normal diaphragm is dome-shaped, with muscle fibers mostly oriented vertically. Muscle contraction causes the dome to descend like a piston drawing air into the lung. Lung hyperinflation in COPD depresses and reduces the radius of curvature of the diaphragm, causing its fibers to shorten and orient more horizontally; shortened fibers are mechanically disadvantaged and generate less tension for a given neural input. Chronic fiber shortening reduces muscle mass via a reduction in the number of sarcomeres arranged in series; consequently, the remaining sarcomeres lengthen, partially restoring the tension generated but reducing contractile fiber shortening for a given neural input.28 Contractile shortening of the flattened diaphragm is, in fact, counterproductive because it pulls the ribcage inward and reduces inspiratory thoracic volume. Thus, "atrophy" of the flattened diaphragm preserves the contractile efficiency of the remaining fibers and minimizes the detrimental mechanical effects of hyperinflation. Although mechanical disadvantage seems to be the major reason favoring diaphragm atrophy in moderate COPD, chronic hypoxemia, physical deconditioning, and malnutrition in severe COPD further contribute to diaphragm weakness.
Skeletal muscle weakness and atrophy is common in COPD and directly related to the decline in flow rates29; the main symptom limiting exercise is often leg fatigue instead of dyspnea. On exercise, muscle metabolism is marked by depleted high-energy phosphate stores, impaired oxidative enzymatic capacity, and early onset of glycolysis30; changes correlate with reductions in vital capacity, handgrip strength, and skeletal muscle mass. Muscle protein concentration and slow-twitch oxidative fibers are reduced while glycolytic enzymes are elevated.31 Abnormalities are not responsive to long-term O2 therapy31 and only partially alleviated by exercise training.32 One potential explanation for skeletal muscle weakness is the excessive O2 cost of breathing, causing respiratory muscles to compete with locomotive muscles for a finite O2 delivery, shown by an inverse relationship between work of breathing and leg muscle blood flow in normal subjects during exercise even as total body O2 uptake continues to increase.33 In restrictive lung disease, nearly 50% of any further increment in O2 delivery near peak exercise is required by respiratory muscles just to sustain the ventilatory pump34; exercise may be curtailed by insufficient O2 delivery to locomotive muscles, causing combined peripheral and respiratory muscle fatigue. Long-term depression of muscle activity leads to fiber atrophy, and muscle capacity is downsized to match the diseased lung.
If ventilatory or gas exchange capacity is the bottleneck, enhancing skeletal muscle O2 transport should have no effect on
O2max. However, exercise training in COPD increases
O2max modestly but significantly (12% to 14%) without improving ventilatory capacity or DL.32,35 In postpneumonectomy patients,
O2max, ventilatory capacity, and cardiac output are all reduced by 50%.3,34 Exercise training has little effect on ventilatory capacity or maximal cardiac output, but it significantly increases peripheral O2 extraction, consistent with that seen in normal untrained subjects, and is associated with a proportional enhanced
O2max.36 These data are in keeping with coordinated adaptation.
Chronic Heart Failure
Skeletal muscle dysfunction often develops in chronic heart failure (CHF) and imposes a major limitation on O2 transport.25 Muscle strength, endurance, O2 extraction, and oxidative enzymes are downregulated, with increasing reliance on anaerobic metabolism. Muscle biochemical and histological changes37 are similar to those in chronic lung disease and are detectable before functional abnormality becomes apparent. Potential pathogenesis includes underperfusion, deconditioning, malnutrition, and elevated neurohormones; there is no evidence of neurogenic myopathy. Respiratory muscle tends to be more impaired than locomotive muscles.38,39 Ventilatory efficiency is reduced, as evidenced by an elevated minute ventilation for a given CO2 output.40 Inhomogeneous ventilation-perfusion distribution increases ventilatory dead space and loading, obligating a higher respiratory muscle O2 demand and activating muscle afferents that exaggerate dyspnea. In the presence of normal arterial blood gases, an increased ventilation-to-CO2 output slope is an independent prognostic factor for survival.40 Dyspnea in CHF is poorly correlated with objective hemodynamic measures but highly correlated with respiratory muscle strength38; the latter has also emerged as an independent predictor of prognosis.
If impaired cardiac output is the bottleneck in CHF, improving aerobic capacity of skeletal or respiratory muscle should have little effect on
O2max. However, exercise training in stable CHF increases
O2max by
20% only due to improved peripheral O2 extraction and leg blood flow, associated with reduced muscle lactate production but no change in maximal cardiac output.41 Selective respiratory muscle training in CHF relieves dyspnea and improves respiratory muscle strength and endurance by 40% to 50%, whereas
O2max increases modestly by 14%.42 A similar myopathic spectrum is seen in chronic renal failure; exercise training in hemodialysis patients significantly improves submaximal exercise tolerance with a small increase in
O2max in half of the patients attributable entirely to improved peripheral O2 extraction without enhancement of cardiovascular O2 delivery.43 This response pattern transcends specific disease cause and supports coordinated adaptation as a unifying homeostatic principle.
| Concept and Practical Application |
|---|
|
|
|---|
Environmental hypoxia and cardiopulmonary disease selectively reduce O2 transport reserves, triggering coordinated structural remodeling that downregulates muscle aerobic capacity. For example, it makes little sense for an athlete who develops CHF to carry the extra weight of highly oxidative muscle that can no longer be used. Thus, seemingly "maladaptive" responses may actually optimize the efficiency of the system at a lower functional level. In stable chronic cardiopulmonary disease and acclimatized highlanders, O2 transport can potentially be as well-matched as in the Olympic athlete at sea level; maximal O2 flux is determined not just by the primary disorder but by all steps of the pathway. Enhancing any individual capacity raises
O2max only modestly; all capacities must be simultaneously enhanced before a proportionally large increase in
O2max can be achieved. Even correction of the primary disorder will only partially normalize O2 transport unless all other steps are addressed equally. Indeed, after heart or lung transplantation,44,45
O2max remains at 50% to 60% of normal; significant long-term functional, histological, and biochemical impairment persists in skeletal muscles. Immunosuppressive therapy, deconditioning, and possible irreversible end-organ destruction complicates the data interpretation; however, they do not contradict the basic tenet of coordinated adaptation.
Within this framework, general therapeutic measures that maximize the aerobic capacity of each transport component (muscular conditioning, nutrition, correction of anemia) are as important as specific treatment (inducing bronchodilation in COPD or reducing afterload in CHF). In practice, coordinated adaptation provides rational support for routine prescription of long-term physical training in chronic cardiopulmonary disease. The inability to dramatically increase
O2max with training in patients is expected and should not be construed as failure of the training regimen. Physical training enhances submaximal endurance as well as the feeling of well-being, even if large improvement of
O2max does not occur. In addition, patients are often disproportionately debilitated due to fear of symptoms; consequently,
O2max is impaired more than expected from the reduction in maximal DL, cardiac output, or ventricular ejection fraction. Maintaining long-term fitness ensures that all O2 transport steps are matched within the constraints of the primary disorder and that the entire metabolic cascade is as efficient as possible; optimization is critical because patients can ill afford metabolic energy wastage. Optimization also ensures that patients are poised to realize the maximum benefit from any specific therapy aimed at correcting the underlying disorder.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Hsia CCW, McBrayer DG, Ramanathan M. Reference values of pulmonary diffusing capacity during exercise by a rebreathing technique. Am J Respir Crit Care Med. 1995; 152: 658665.[Abstract]
3. Hsia CCW, Ramanathan M, Estrera AS. Recruitment of diffusing capacity with exercise in patients after pneumonectomy. Am Rev Respir Dis. 1992; 145: 811816.[Medline] [Order article via Infotrieve]
4.
Takeda S, Hsia CCW, Wagner E, et al. Compensatory alveolar growth normalizes gas exchange function in immature dogs after pneumonectomy. J Appl Physiol. 1999; 86: 13011310.
5. Saltin B, Blomqvist G, Mitchell JH, et al. Response to exercise after bed rest and after training. Circulation. 1968; 38 (suppl): VII1VII78.
6. Srere PA. Wanderings (wonderings) in metabolism. Biol Chem Hoppe Seyler. 1993; 374: 833842.[Medline] [Order article via Infotrieve]
7. Niederberger P, Prasad R, Miozzari G, et al. A strategy for increasing an in vivo flux by genetic manipulations. Biochem J. 1992; 287: 473479.
8. Holloszy JO, Oscai LB, Don IJ, et al. Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise. Biochem Biophys Res Commun. 1970; 40: 13681373.[Medline] [Order article via Infotrieve]
9.
Fee LL, Smith RM, English MB. Enhanced ventilatory and exercise performance in athletes with slight expiratory resistive loading. J Appl Physiol. 1997; 83: 503510.
10.
Johnson BD, Saupe KW, Dempsey JA. Mechanical constraints on exercise hyperpnea in endurance athletes. J Appl Physiol. 1992; 73: 874886.
11. Weibel ER. Symmorphosis. Cambridge, Mass: Harvard University Press; 2000.
12.
Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol. 1968; 25: 664671.
13. Mellemgaard K. The alveolar-arterial oxygen difference: Its size and components in normal man. Acta Physiol Scand. 1967; 67: 1020.
14.
McClaran SR, Babcock MA, Pegelow DF, et al. Longitudinal effects of aging on lung function at rest and exercise in healthy active fit elderly adults. J Appl Physiol. 1995; 78: 19571968.
15.
Hagberg JM, Allen WK, Seals DR, et al. A hemodynamic comparison of young and older endurance athletes during exercise. J Appl Physiol. 1985; 58: 20412046.
16.
Ogawa T, Spina RJ, Martin WH, et al. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation. 1992; 86: 494503.
17.
Wagner PD, Gillespie JR, Landgren GL, et al. Mechanism of exercise-induced hypoxemia in horses. J Appl Physiol. 1989; 66: 122733.
18.
Wagner PD, Gale GE, Moon RE, et al. Pulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol. 1986; 61: 260270.
19. Saltin B, Grover RF, Blomqvist CG, et al. Maximal oxygen uptake and cardiac output after 2 weeks at 4,300 m. J Appl Physiol. 1968; 25: 400409.
20. Grover RF, Weil JV, Reeves JT. Cardiovascular adaptation to exercise at high altitude. Exerc Sport Sci Rev. 1986; 14: 269302.[Medline] [Order article via Infotrieve]
21.
Reeves JT, Groves BM, Sutton JR, et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol. 1987; 63: 531539.
22. Hoppeler H, Kleinert E, Schleger C, et al. Morphological adaptations of human skeletal muscle to chronic hypoxia. Int J Sports Med. 1990; 11: S3S9.
23. Howald H, Pette D, Simoneau JA, et al. Effects of chronic hypoxia on muscle enzyme activities. Int J Sports Med. 1990; 11: S10S14.
24.
Stewart RI, Lewis CM. Cardiac output during exercise in patients with COPD. Chest. 1986; 89: 199205.
25.
Jones NL, Killian KJ. Exercise limitation in health and disease. N Engl J Med. 2000; 343: 632641.
26.
American Thoracic Society, European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159: S1S40.
27.
Thurlbeck WM. Diaphragm and body weight in emphysema. Thorax. 1978; 33: 483487.
28. De Troyer A, Pride NB. The chest wall and respiratory muscles in chronic obstructive pulmonary disease.In: Roussos C, ed. The Thorax. 2nd ed. New York: Marcel Dekker; 1995: 19752006.
29.
Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 158: 629634.
30. Kutsuzawa T, Shioya S, Kurita D, et al. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am Rev Respir Dis. 1992; 146: 10191024.[Medline] [Order article via Infotrieve]
31. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995; 151: 374377.[Abstract]
32. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996; 154: 442447.[Abstract]
33.
Harms CA, Babcock MA, McClaran SR, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol. 1997; 82: 15731583.
34. Hsia CCW, Peshock RM, Estrera AS, et al. Respiratory muscle limitation in patients after pneumonectomy. Am Rev Respir Dis. 1993; 147: 744752.[Medline] [Order article via Infotrieve]
35. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997; 155: 15411551.[Abstract]
36.
Hijazi OM, Ramanathan M, Estrera AS, et al. Fixed maximal stroke index in patients after pneumonectomy. Am J Respir Crit Care Med. 1998; 157: 16231629.
37.
Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990; 81: 518527.
38.
Hammond MD, Bauer KA, Sharp JT, et al. Respiratory muscle strength in congestive heart failure. Chest. 1990; 98: 10911094.
39.
Lindsay DC, Lovegrove CA, Dunn MJ, et al. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J. 1996; 17: 12391250.
40.
Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure. Prognostic impact. Circulation. 2000; 101: 28032809.
41.
Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Circulation. 1988; 78: 506515.
42.
Mancini DM, Henson D, La Manca J, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure. Circulation. 1995; 91: 320329.
43. Moore GE, Parsons DB, Stray-Gundersen J, et al. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis. 1993; 22: 277287.[Medline] [Order article via Infotrieve]
44.
Stratton JR, Kemp GJ, Daly RC, et al. Effects of cardiac transplantation on bioenergetic abnormatlities of skeletal muscle in congestive heart failure. Circulation. 1994; 89: 16241631.
45. Oelberg DA, Systrom DM, Markowitz DH, et al. Exercise performance in cystic fibrosis before and after bilateral lung transplantation. J Heart Lung Transplant. 1998; 17: 11041112.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E. L. Rezende, K. A. Hammond, and M. A. Chappell Cold acclimation in Peromyscus: individual variation and sex effects in maximum and daily metabolism, organ mass and body composition J. Exp. Biol., September 1, 2009; 212(17): 2795 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mezzani, U. Corra, C. Andriani, A. Giordano, R. Colombo, and P. Giannuzzi Anaerobic and aerobic relative contribution to total energy release during supramaximal effort in patients with left ventricular dysfunction J Appl Physiol, January 1, 2008; 104(1): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Garland Jr and S. A. Kelly Phenotypic plasticity and experimental evolution J. Exp. Biol., June 15, 2006; 209(12): 2344 - 2361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sofia, M. Maniscalco, P. Carratu, and O. Resta End points for pulmonary arterial hypertension: a way backward Eur. Respir. J., November 1, 2004; 24(5): 890 - 891. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |